Home > Healthcare > Medical Devices > Diagnostic Devices > Coronary Heart Disease Diagnostic Imaging Devices Market

Coronary Heart Disease Diagnostic Imaging Devices Market Trends

Report ID: GMI11128
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Coronary Heart Disease Diagnostic Imaging Devices Market Trends

Continuous advancements in imaging technology, such as the development of high-resolution and 3D imaging systems, are enhancing the accuracy and reliability of coronary heart disease diagnoses. These technological innovations are propelling market growth by providing more precise and non-invasive diagnostic options.
Moreover, there is a rising preference for non-invasive diagnostic methods, which are safer and more comfortable for patients. Non-invasive imaging technologies, such as CT scanners and MRI, are increasingly being adopted, further boosting the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Coronary heart disease diagnostic imaging devices industry size was valued at around USD 1.8 billion in 2023 and is estimated to record a 6.6% CAGR from 2024 to 2032, due to increasing prevalence of coronary heart disease.

The computed tomography segment of market is predicted to reach USD 443.8 million by 2032, as CT scans offer high-resolution imaging that is crucial for visualizing the coronary arteries and detecting blockages or narrowing with major detail.

The coronary heart disease diagnostic imaging devices market value in the U.S. is projected to reach USD 1.3 billion by 2032, as coronary heart disease remains a leading cause of death in the U.S. due to aging, poor diet, lack of physical activity, and smoking.

CHISON Medical Technologies Co., Ltd., Esaote SPA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Neusoft Corporation, Samsung Electronics Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Shimadzu Corporation among others.